It’s March Madness, the Breast Friends Madness way!
In Episode 3, Dr. Jason Mouabbi and Dr. Paolo Tarantino are hitting the court to break down the heavy hitters of 2025 using our "Breast Friends Madness" bracket.
Among the featured lineups are studies ranging from the practice-changing results of the DESTINY-Breast trials to the strategic shifts in SERENA-6, monarchE, and ASCENT-04. We’re scouting the data officially rewriting the playbook for HER2+, TNBC, and HR+ care.
EVERY study in this bracket is a WIN for our patients. Let’s get ready to highlight the trials moving the field forward.
👉 Cast your vote here: tinyurl.com/breastfriendsmadness
▶️ Watch on YouTube
🎧 Listen on Spotify, Apple Podcasts, iHeartRadio, CastBox & Amazon Music
#BreastCancer #Oncology #OncologyPodcast #CancerResearch #ClinicalTrials #HER2Positive #TripleNegativeBreastCancer #MedEd #MedicalOncology